Multifaceted approaches to tumor microenvironment modulation and immune checkpoint targeting

Keyphrases

• Immune Checkpoint 100%
• Tumor Microenvironment 100%
• Tumor Microenvironment Modulation 100%
• In Cancer 50%
• Tumor 25%
• Lymphoma 25%
• Immune System 25%
• Immune Cells 25%
• Cancer Cells 25%
• New Targets 25%
• Innovative Therapies 25%
• In Vivo Experiment 25%
• In Vitro Experiment 25%
• Overexpressing 25%
• Extracellular Matrix 25%
• Therapeutic Strategies 25%
• Promising Target 25%
• Reducing Potential 25%
• Protein Engineering 25%
• Bispecific Antibody 25%
• Novel Protein 25%
• Complex Disease 25%
• Programmed Death-ligand 1 (PD-L1) 25%
• Protein Targeting 25%
• Tumor Site 25%
• Engineering Strategies 25%
• Adaptive Immune Response 25%
• Negatively Regulate 25%
• CD27 25%
• Innate Immune Response 25%
• Costimulation 25%
• Potential Side Effects 25%
• Anticancer Immune Response 25%
• Immune Escape 25%
• Inhibitory Pathways 25%
• Tumor Immunity 25%
• Systemability 25%
• Immune Monitoring 25%
• Innate Immune Cells 25%
• Uveal Melanoma 25%
• EGFR Protein 25%
• Anticancer Immunity 25%
• Bispecific Fusion Protein 25%

Immunology and Microbiology

• Immunocompetent Cell 100%
• Immunity 100%
• Immune Response 50%
• Cancer Cell 50%
• Adaptive Immune System 50%
• Bispecific Antibody 50%
• Tumor Immunity 50%
• Innate Immune System 50%
• Protein Targeting 50%
• Extracellular Matrix 50%
• Protein Engineering 50%
• Immune Escape 50%
• Co-Stimulation 50%
• Programmed Death-Ligand 1 50%
• Immune System 50%